nitric oxide

(redirected from Nitric oxide donors)
Also found in: Thesaurus, Medical, Encyclopedia.

nitric oxide

n.
A colorless, poisonous gas, NO, produced by the partial oxidation of atmospheric nitrogen, by cellular metabolism, and as an intermediate during the manufacture of nitric acid from ammonia. In the body, nitric oxide is involved in oxygen transport to the tissues, the transmission of nerve impulses, and other physiological activities.

nitric oxide

n
(Elements & Compounds) a colourless slightly soluble gas forming red fumes of nitrogen dioxide in air. Formula: NO. Systematic name: nitrogen monoxide

ni′tric ox′ide


n.
a colorless, slightly water-soluble gas, NO, an intermediate in the manufacture of nitric acid.
[1800–10]
ThesaurusAntonymsRelated WordsSynonymsLegend:
Noun1.nitric oxide - a poisonous red-brown gas (NO)
gas - a fluid in the gaseous state having neither independent shape nor volume and being able to expand indefinitely
References in periodicals archive ?
BIOC51 is a novel polyglucosamine biopolymer covalently modified with N diazeniumdiolate nitric oxide donors to facilitate spontaneous (without the need of enzymes) and controlled NO release.
Nicox and Re-Vana Therapeutics have announced a research partnership to study the potential of integrating the formers stand-alone nitric oxide donors with Re-Vanas EyeLief drug delivery platform for the reduction of IOP.
Klink, Nitric oxide donors reduce the invasion ability of ovarian cancer cells in vitro, Anticancer Drugs, 25, 1141 (2014).
Activation of pig oocytes using nitric oxide donors," Molecular Reproduction and Development, vol.
Impaired L-arginine-nitric oxide pathway has been suggested to be a subtle cause of URA and treatment with nitric oxide donors is reported as a significant success in some studies (11-13).
Nitric oxide donors are not new they have been used as vascular smooth muscle relaxants for a long time in cardiac conditions.
There is now considerable evidence that nitric oxide is involved in the regulation of myometrial contractility during pregnancy, where nitric oxide donors have been applied on myometrium in vitro, inhibition of spontaneous and oxytocin-induced activity was found when amplitude or force of contraction was measured.
Antiplatelet effects of endothelium-derived relaxing factor and nitric oxide donors.
Animal studies using nitric oxide donors such as nitroglycerin, isosorbide mononitrate, and dinitrate showed that these compounds can prevent bone loss associated with estrogen deficiency and glucocorticoid use.